Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/04/1996 | EP0745069A1 Pharmaceutical piperazine compounds |
12/04/1996 | EP0745068A1 Heteroaryl-substituted deoxy glycero-phosphoethanolamines |
12/04/1996 | EP0745066A1 Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof |
12/04/1996 | EP0745065A1 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics |
12/04/1996 | EP0745063A1 Substituted biphenyl derivatives as phosphodiesterase inhibitors |
12/04/1996 | EP0744954A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
12/04/1996 | EP0744952A1 Method for treating vascular obstructions caused by abnormal cells |
12/04/1996 | EP0744951A1 Process for producing a sterile prednisolone gel |
12/04/1996 | EP0744950A1 Agent for prophylaxis and treatment of thromboxane a 2?-mediated diseases |
12/04/1996 | EP0744948A1 Protease inhibitors |
12/04/1996 | EP0744947A1 Modified-release metronidazole compositions and methods for making and using same |
12/04/1996 | EP0744946A1 Compositions containing micronized nebivolol |
12/04/1996 | EP0744945A1 Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol |
12/04/1996 | EP0744944A1 Sexual steroid-containing transdermal therapeutic systems |
12/04/1996 | EP0744943A1 Desogestrel-containing transdermal application agent |
12/04/1996 | EP0744940A1 Drugs, vaccines and hormones in polylactide coated microspheres |
12/04/1996 | EP0684765A4 Treating alopecia by administering 5-alpha-reductase inhibiting compounds. |
12/04/1996 | EP0630230B1 Pharmaceutical inhalation compositions |
12/04/1996 | EP0547191B1 Particulate vector having selective tropism, method of preparation and pharmaceutical composition |
12/04/1996 | EP0485486B1 Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
12/04/1996 | EP0440738B1 Treatment of hypertension |
12/04/1996 | EP0275297B1 Bisplatinum complexes as chemotherapeutic agents |
12/04/1996 | CN1137289A Protease-containing cleaning compositions |
12/04/1996 | CN1137275A O-aryl O-alkyl O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity |
12/04/1996 | CN1137274A 6-oxo-nucleosides useful as immunosuppressants |
12/04/1996 | CN1137273A Quinolizinone type compounds |
12/04/1996 | CN1137270A Novel imidazole derivative and process for producing the same |
12/04/1996 | CN1137269A Short-acting dihydropyridines |
12/04/1996 | CN1137268A Amidino derivatives useful as nitric oxide synthase inhibitors |
12/04/1996 | CN1137267A N,N'-bis (2-hydroxybenzyl) ethylenediamine-N,N'-diacetic acid derivatives as chelating agents |
12/04/1996 | CN1137237A Method of treating androgenic alopecia with 5-alpha reductase inhibitors |
12/04/1996 | CN1137236A Paroxetine tablets and process to prepare them |
12/04/1996 | CN1137223A Growth promoting composition for fish |
12/04/1996 | CN1137039A Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz (b,f) oxepines |
12/04/1996 | CN1137037A Quinazoline derivatives |
12/04/1996 | CN1137036A Benzonitriles and benzofluorides |
12/04/1996 | CN1137035A Basic group substituted benzoyl guanidine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same |
12/04/1996 | CN1136960A Polyamines and polypeptides useful as antagonisis of excitatory amino acid neurotransmitiers and/or as blockers of calcium channels |
12/04/1996 | CN1136921A Pharmaceutical agents for treatment of alzheimer's disease |
12/04/1996 | CN1136920A Use of benzopyran derivatives for production of pharmaceutical compositions |
12/04/1996 | CN1136919A Enteric soluble glutamine |
12/04/1996 | CN1033456C Separation-extraction technology of cyclovirobuxine |
12/04/1996 | CN1033455C 1-methylcarbapenem derivatives and process for preparation thereof |
12/04/1996 | CN1033454C Process for preparing 4-|(2-benzothiazolyl) methylamino¨-alpha-|(3,4-difluorophinoxy) methyl¨-1-piperidineethanol |
12/04/1996 | CN1033453C Preparation process for pyridylthiozolidine carboxylic amide derivative |
12/04/1996 | CN1033451C Alpha-substituted benzenemethanamine derivatives |
12/03/1996 | US5581011 Antihistamine intermediates |
12/03/1996 | US5581006 Synthesis of 19-nor vitamin D compounds |
12/03/1996 | US5580998 Process for preparing taxoids |
12/03/1996 | US5580997 Baccatin III derivatives |
12/03/1996 | US5580989 Antiallergens, antiinflammatory agents |
12/03/1996 | US5580987 Process for preparing 1-aminoacetamidopyrroles |
12/03/1996 | US5580985 Substituted pyrazoles for the treatment of inflammation |
12/03/1996 | US5580984 Retroviral protease inhibiting compounds |
12/03/1996 | US5580982 Antidepressants; anticholinergic agents; alzheimer's disease; amine oxidase inhibitors |
12/03/1996 | US5580903 Liver regeneration accelerator |
12/03/1996 | US5580902 Applying ethyl pyruvate solutions to reduce facial wrinkling |
12/03/1996 | US5580901 Percutaneous anesthetics |
12/03/1996 | US5580900 Macrocyclic compounds |
12/03/1996 | US5580899 Stably associate with lipid carrier for improved delivery |
12/03/1996 | US5580898 Administering taxol to patients with alzheimer's disease having a deficiency in normal tau protein |
12/03/1996 | US5580895 1,5-benzodiazepine derivatives |
12/03/1996 | US5580893 Treatment and prevention of angina pectoris; side-effect reduction; vasodilation |
12/03/1996 | US5580892 Antidiarrhetic, antispastic, antiepileptic agents; diuretics |
12/03/1996 | US5580891 Antipsychotic agents, analgesics |
12/03/1996 | US5580890 Psychological disorders |
12/03/1996 | US5580888 Administering for therapy and prophylaxis of asthma; potent phosphodiesterase iv isoenzyme inhibitors |
12/03/1996 | US5580887 1- (arylthioalkyl , arylaminoalkyl or arylmethylenealkyl) -4- (heteroaryl) piperidines and related compounds useful as anti-psychotics and analgesics |
12/03/1996 | US5580886 Cis-2-[(4-heteroaryl-1-piperidinyl)alkyl]hexahydro-1H-isoindole-1,3(2H)-diones and related compounds and their therapeutic utility |
12/03/1996 | US5580885 5-HT4 receptor antagonists |
12/03/1996 | US5580884 Antimicrobial agents |
12/03/1996 | US5580882 Use of substituted quinoline carboxamide |
12/03/1996 | US5580881 1,2,3,5,6,7,8,8a-Octahydro-5,5,8a-trimethyl-(8aβ)-6-isoquinolineamine derivatives, preparation method therefor and therapeutical use thereof |
12/03/1996 | US5580880 Administering a derivative of spirooxathiolane-quinuclidine |
12/03/1996 | US5580879 N-[(4-heteroaryl-1-pyrrolidinyl)alkyl]-1H-benz[DE]isoquinoline-1;3(2H)-diones and related compounds and their therapeutic utility |
12/03/1996 | US5580878 Treating sleep disorders |
12/03/1996 | US5580876 Administering together with nalmefene; side effect reduction |
12/03/1996 | US5580875 Antipsychotic and analgesic agents |
12/03/1996 | US5580874 Therapy for side effects of immunosuppressive agents |
12/03/1996 | US5580873 Antitumor agents, aids therapy |
12/03/1996 | US5580871 For treatment of congestive heart failure |
12/03/1996 | US5580870 Quinazoline derivatives |
12/03/1996 | US5580869 1N substituted pyrazino[2,3-c]-1,2,6-thiadiazine 2,2-dioxides |
12/03/1996 | US5580867 Myocardial protection during ischemia and reperfusion |
12/03/1996 | US5580866 Therapeutic 1,4-thiazepines |
12/03/1996 | US5580865 2,2-disubstituted cephem sulphones |
12/03/1996 | US5580864 Method of controlling male fertility |
12/03/1996 | US5580860 Pharmaceutical composition containing 2-amino-6-chloropurine-9-β-D-2',3'-dideoxyribofuranoxside |
12/03/1996 | US5580858 Immunosuppressive and tolerogenic modified Lewisx compounds |
12/03/1996 | US5580857 Use of gibberellins for the treatment of prostatitis |
12/03/1996 | US5580789 Method for collecting blood |
12/03/1996 | US5580767 Some of internucleotide linkages within oligonucleotide are phosphorothioate linkages |
12/03/1996 | US5580755 Human pluripotent granulocyte colony-stimulating factor |
12/03/1996 | US5580580 3-aminopyridine or 3,4-diaminopyridine; useful for multiple sclerosis and alzheimer's disease |
12/03/1996 | US5580577 Administering an n-alkanoyl-cysteine or salt |
12/03/1996 | US5580576 Pharmaceutically/storage-stable nicorandil formulations |
12/03/1996 | US5580575 Therapeutic drug delivery systems |
12/03/1996 | US5580574 Including a benzodiazepine antagonist to overcome the sedative effects of the benzodiazepine active ingredient |
12/03/1996 | US5580572 Styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen |
12/03/1996 | US5580571 Nucleoside analogues |